(20S)-Ginsenoside Rg3 is a bioactive triterpene saponin renowned for its neuroprotective, anti-tumor, and cardioprotective properties. This natural compound has garnered significant attention in biomedical research and nutraceutical development due to its ability to modulate cellular signaling pathways and enhance metabolic health.

As a principal tetracyclic triterpenoid saponin in premium ginseng, Ginsenoside Rb1 exhibits proven neuroprotective, anti-diabetic, and cardiometabolic activities through modulation of BDNF signaling and AMPK pathways. Our vertically integrated production delivers 1%-98% HPLC-certified purity grades, empowering pharmaceutical innovations, cosmeceutical breakthroughs, and nutraceutical formulations.

Ginsenoside Rg1 is a bioactive triterpene saponin abundantly found in Panax ginseng and Panax notoginseng. Renowned for its multifaceted pharmacological properties, this natural compound has emerged as a focal point in biomedical research due to its significant neuroprotective, anti-inflammatory, and cardiovascular protective activities.

(20S)-Ginsenoside Rh2 is a bioactive metabolite derived from the root of Panax ginseng (red ginseng), belonging to the dammarane-type tetracyclic triterpenoid saponins 

20(S)-Protopanaxadiol (CAS 30636-90-9) is a high-purity ginsenoside aglycone metabolite, rigorously validated by HPLC to ensure ≥98% quality. As the core bioactive component of Panax ginseng, it serves as an essential reference standard for pharmaceutical research, nutraceutical development, and metabolic studies. This compound demonstrates significant potential in modulating anti-inflammatory, neuroprotective, and anticancer pathways.